dhap
Showing 1 - 6 of 6
Hodgkin Lymphoma Trial in Cologne (DHAP, Everolimus)
Completed
- Hodgkin Lymphoma
- DHAP
- Everolimus
-
Cologne, Germany1st Dept. of Medicine, Cologne University Hospital
Nov 7, 2019
Hodgkin Lymphoma, Refractory, Relapse Trial in Worldwide (DHAP, Brentuximab Vedotin, Autologous Peripheral Blood Stem Cell
Unknown status
- Hodgkin Lymphoma
- +2 more
- DHAP
- +2 more
-
Copenhagen, Denmark
- +12 more
Mar 12, 2018
Adult T-cell Leukemia-Lymphoma Trial in Worldwide (KW-0761, Pralatrexate, gemcitabine plus oxaliplatin)
Completed
- Adult T-cell Leukemia-Lymphoma
- KW-0761
- +3 more
-
Los Angeles, California
- +19 more
Aug 21, 2018
DLBCL Trial in Worldwide (MEDI-551 2 mg/kg, Rituximab, ICE)
Completed
- Diffuse Large B-Cell Lymphoma
- MEDI-551 2 mg/kg
- +5 more
-
Birmingham, Alabama
- +82 more
Feb 8, 2018
Lymphoma Trial in Los Angeles (Amifostine, DHAP)
Completed
- Lymphoma
- Amifostine
- DHAP
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Oct 3, 2012
Non-Hodgkin's Lymphoma Trial in Magdeburg (Rituximab, DHAP, TEC)
Unknown status
- Non-Hodgkin's Lymphoma
- Rituximab
- +3 more
-
Magdeburg, GermanyUniversity of Magdeburg
Oct 5, 2006